Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib. Maso L, Rajak E, Hattori T, Hu Z, et al. Proc Natl Acad Sci U S A 2025;122:e2509012122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maso L, Rajak E, Hattori T, Hu Z, et al. Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib. Proc Natl Acad Sci U S A 2025;122:e2509012122.
PMID: 40737322